As an illustration, it's been demonstrated that prime-dose CsA—but not very low dose CsA—straight inhibits the expression of NFATc1 and IL-two in human T cells from stimulated complete blood samples, assessed by flow cytometry (23). Hence, compared with other cytotoxic immune suppressors, CsA won't kill the immune effector cells but https://troytnfdu.diowebhost.com/84966578/examine-this-report-on-deferoxamine